Chief Scientific Officers take the helm of £30 million dementia Drug Discovery Alliance

Alzheimer’s Research UK has appointed three Chief Scientific Officers to drive its £30million Drug Discovery Alliance. The Alliance, which unites three Drug Discovery Institutes at the University of Cambridge, the University of Oxford and University College London, is a unique drug discovery venture in dementia research.